Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
Leyre Mestre, Francisco Carrillo‐Salinas, Míriam Mecha, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions
Suganya Kanmani, Byung‐Soo Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7551-7551
Open Access | Times Cited: 235
Effect of nutrition on neurodegenerative diseases. A systematic review
Vittorio Emanuele Bianchi, Pomares Fredy Herrera, Laura Rizzi
Nutritional Neuroscience (2019) Vol. 24, Iss. 10, pp. 810-834
Closed Access | Times Cited: 188
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 121
Regulation of common neurological disorders by gut microbial metabolites
Jeongho Park, Chang H. Kim
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 12, pp. 1821-1833
Open Access | Times Cited: 62
Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis
Luís Almeida, Ayesha Dhillon-LaBrooy, Carla N. Castro, et al.
Immunity (2020) Vol. 54, Iss. 1, pp. 68-83.e6
Open Access | Times Cited: 69
Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice
Xiuli Lin, Yingying Liu, Lili Ma, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Targeting the gut to treat multiple sclerosis
Laura Ghezzi, Claudia Cantoni, Gabriela Veronica Pinget, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 44
Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review
Himanshi Yadav, Jaldhi, Rati Bhardwaj, et al.
Life Sciences (2023) Vol. 330, pp. 122022-122022
Closed Access | Times Cited: 19
Microbes, microglia, and pain
Zoë Dworsky-Fried, Bradley J. Kerr, Anna M.W. Taylor
Neurobiology of Pain (2020) Vol. 7, pp. 100045-100045
Open Access | Times Cited: 47
Gut microbiota composition modulates inflammation and structure of the vagal afferent pathway
Jiyoung S. Kim, Rebecca Kirkland, Sunhye Lee, et al.
Physiology & Behavior (2020) Vol. 225, pp. 113082-113082
Open Access | Times Cited: 46
Monocyte mobilisation, microbiota & mental illness
Marcel van de Wouw, Marcus Boehme, Timothy G. Dinan, et al.
Brain Behavior and Immunity (2019) Vol. 81, pp. 74-91
Open Access | Times Cited: 37
Farnesol induces protection against murine CNS inflammatory demyelination and modifies gut microbiome
Lacey B. Sell, Christina C. Ramelow, Hannah M. Kohl, et al.
Clinical Immunology (2021) Vol. 235, pp. 108766-108766
Open Access | Times Cited: 28
How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process
Leyre Mestre, Francisco Carrillo‐Salinas, Ana Feliú, et al.
Gut Microbes (2020) Vol. 12, Iss. 1, pp. 1813532-1813532
Open Access | Times Cited: 31
B Cells and Microbiota in Autoimmunity
María Botia-Sánchez, Marta E. Alarcón‐Riquelme, Georgina Galicia
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4846-4846
Open Access | Times Cited: 26
Dynamic modulation of spleen germinal center reactions by gut bacteria during Plasmodium infection
Rabindra K. Mandal, Joshua E. Denny, Ruth Namazzi, et al.
Cell Reports (2021) Vol. 35, Iss. 6, pp. 109094-109094
Open Access | Times Cited: 24
Microbiota’s Role in Diet-Driven Alterations in Food Intake: Satiety, Energy Balance, and Reward
Allison W. Rautmann, Claire B. de La Serre
Nutrients (2021) Vol. 13, Iss. 9, pp. 3067-3067
Open Access | Times Cited: 24
Microglial cells: Sensors for neuronal activity and microbiota-derived molecules
Giuseppina D’Alessandro, Francesco Marrocco, Cristina Limatola
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Gut Microbiota-Immune System Interactions in Health and Neurodegenerative Diseases: Insights into Molecular Mechanisms and Therapeutic Applications
Rengasamy Balakrishnan, Seungha Kang, Ji Yeon Lee, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections
Małgorzata Ciurkiewicz, Vanessa Herder, Andreas Beineke
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1705-1705
Open Access | Times Cited: 25
Gut microbiota shape B cell in health and disease settings
Baichao Yu, Luman Wang, Yiwei Chu
Journal of Leukocyte Biology (2021) Vol. 110, Iss. 2, pp. 271-281
Closed Access | Times Cited: 21
Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves’ Disease Before and After Methimazole Treatment
Mengxue Yang, Xiaodi Zheng, Yueyue Wu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 15
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
Nirav Bhatia, Manjiri P. Jalgaonkar, Anuja Balu Hargude, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 7, pp. 1008-1030
Closed Access | Times Cited: 15
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?
Hannah M. Kohl, Andrea Castillo, Javier Ochoa‐Repáraz
Diseases (2020) Vol. 8, Iss. 3, pp. 33-33
Open Access | Times Cited: 23
Gut flora in multiple sclerosis: implications for pathogenesis and treatment
Weiwei Zhang, Ying Wang, Mingqin Zhu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1480-1488
Open Access | Times Cited: 7
The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis
Rocío Benítez‐Fernández, Carmen Gil, Carmen Guaza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14378-14378
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top